TRAVERE THERAPEUTICS INC

CUSIP: 89422GAA5 Class: Convertible Debt

OAKTREE CAPITAL MANAGEMENT LP's Holding History (CIK: 0000949509)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025
Shares 9,213,000 Value ($000) $10,433 Avg Close — Range —
Q2 2025
Shares 7,741,000 Value ($000) $7,393 Avg Close — Range —
Q1 2025
Shares 7,241,000 Value ($000) $7,234 Avg Close — Range —
Q4 2024
Shares 11,500,000 Value ($000) $11,009 Avg Close — Range —
Q3 2024
Shares 30,000,000 Value ($000) $25,920 Avg Close — Range —
Q1 2023
Shares 1,500,000 Value ($000) $1,475 Avg Close — Range —